Apply for funding
The page covers IHI’s current and future EU health research and innovation funding opportunities and offers advice on preparing proposals.
ihi.europa.euCrawled Oct 16, 2026
The page covers IHI’s current and future EU health research and innovation funding opportunities and offers advice on preparing proposals.
The company's projects have an impact on health research in areas such as cancer, diabetes, dementia, mental health, and clinical trials.
The page covers IHI’s current health research and innovation funding opportunities through its open calls for proposals.
The company presents its health research and innovation projects, their results and impacts, and their participants.
The page provides health research and innovation projects with resources and advice on formal reporting, communication, dissemination, exploitation, and other topics.
The benefits of being part of a collaborative IHI health research & innovation project include funding, networking, and access to resources and expertise.
Guidance for funding applicants and projects on when and how to interact with regulators to ensure their health research makes a difference.
The page explains how health research and innovation topics for IHI calls for proposals are selected and developed.
Dementia affects millions of people in Europe and the number is continually rising.
Over 33 million people in the EU suffer from diabetes, and the number is set to rise.
A summary of requirements for projects on access to scientific publications, the results of clinical research, and the management of research data.
IHI welcomes ideas for potential topics for its calls for proposals through its Ideas Incubator.
A blood protein may predict type 2 diabetes up to 19 years before disease onset. The research was funded by the Innovative Medicines Initiative (IMI).
IHI launches under Horizon Europe to unite sectors and drive cross-disciplinary health innovation, aiming for real impact on unmet medical needs.
The event presents results from Innovative Medicines Initiative (IMI) projects on paediatric medicine development, an area with ongoing challenges and unmet medical needs.
IMI’s PROMISE project targets RSV, a respiratory infection in kids and the elderly, to improve vaccines, diagnostics and public health strategies.
New EPND platform will unite data and sample infrastructures to speed up biomarker discovery for neurodegenerative diseases.
The company shares news about its calls for proposals, activities, and events, as well as updates and results from its health research and innovation projects.
The page lists opportunities to join the IHI team.
The page lists topics in the pipeline for future IHI calls for proposals.
IHI call 2 is a two-stage call with topics on cardiovascular disease and early feasibility studies.
IHI call 5 is a single-stage call with topics on the 3Rs, theranostics, stroke management and synthetic data.
The Executive Director is responsible for the day-to-day management of IHI and the Programme Office.
The Governing Board is the main decision-making body of IHI.
IHI is a public-private partnership (PPP) between the EU and Europe’s health industries.
The Programme Office implements the work programme by running calls for proposals and monitoring the resulting projects.
The SIP provides advice on matters relating to IHI’s research and innovation activities.
The SRG is consulted on a range of issues, including draft call topics and links to national and regional initiatives.
IHI research and innovation projects are collaborative, and the page offers tips on finding partners for applicant consortia.
IHI replaced IMI (Innovative Medicines Initiative) at the end of 2021. The page explains what changed and what stayed the same.
IHI aims to translate health research and innovation into benefits for patients and society and advance interdisciplinary research in Europe.
The page explains how people can contribute ideas and resources to shape IHI’s health research and innovation programme.
IHI’s governance bodies reflect its role as a health public-private partnership and provide input from scientific and national stakeholders.
Organizations can support IHI as contributing partners in specific areas of health research and innovation.
IHI is an EU public-private partnership funding collaborative health research & innovation under Horizon Europe, to improve lives and advance healthcare.
The company processes personal data.
The page explains how to formally request access to a document and provides information on meetings between IHI management and interest representatives.